All Insiders Activity for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.2497   0.0297 (+13.50%) Volume: 2.18m 8:00 PM EDT 21-Aug-2019
After Hours:  $ 0.2499   0.0002 (+0.08%) Volume: 17.58k 7:32 PM EDT 21-Aug-2019
Name: Transaction:
Date Name: Shares Transaction Value
03/05/19 Mark S. Berger,
Chief Medical Officer
3,500 Option Exercise at $0.60 per share. $2,100
02/21/19 Sandesh Seth,
8,125 Option Exercise at $0.60 per share. $4,875
12/10/18 Steven O'Loughlin,
VP, Finance and Corporate Dev.
10,000 Buy at $0.435 per share. $4,350
12/10/18 Sandesh Seth,
10,000 Buy at $0.4372 per share. $4,372
11/19/18 Dale L. Ludwig,
Chief Scientific Officer
10,000 Buy at $0.4499 per share. $4,499
07/17/18 Sandesh Seth,
10,000 Buy at $0.79 per share. $7,900
07/13/18 Richard I. Steinhart,
75,000 Acqusition at $0.783 per share. $58,725
07/13/18 Mark S. Berger,
Chief Medical Officer
250,000 Acqusition at $0.783 per share. $195,750
07/13/18 Sandesh Seth,
1,000,000 Acqusition at $0.783 per share. $783,000
07/13/18 Ajit S. Shetty,
75,000 Acqusition at $0.783 per share. $58,725
07/13/18 Nitya G. Ray,
Executive Vice President
75,000 Acqusition at $0.783 per share. $58,725
07/13/18 Steven O'Loughlin,
VP, Finance and Corporate Dev.
265,000 Acqusition at $0.783 per share. $207,495
07/13/18 C. David Nicholson,
75,000 Acqusition at $0.783 per share. $58,725
07/13/18 Jeffrey W. Chell,
75,000 Acqusition at $0.783 per share. $58,725
06/15/18 Steven O'Loughlin,
VP, Finance and Corporate Dev.
12,000 Buy at $0.50 per share. $6,000
  Page 1 of 6   Next Page
View Section 16 Filings (Forms 3,4,5) for ATNM Insider Summary For ATNM